Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Erstveröffentlichung
2013
Authors
Cudkowicz, Merit E.
van den Berg, Leonard H.
Shefner, Jeremy M.
Mitsumoto, Hiroshi
Mora, Jesus S.
et al.
Wissenschaftlicher Artikel


Published in
Lancet Neurology ; 12 (2013), 11. - S. 1059-1067. - ISSN 1474-4422. - eISSN 1474-4465
Link to publication
https://dx.doi.org/10.1016/S1474-4422(13)70221-7
Institutions
UKU. Klinik für Neurologie
Subject headings
[Free subject headings]: CLINICAL-TRIALS | ALS | PROGRESSION | LITHIUM | PRAMIPEXOLE | MULTICENTER | ENANTIOMER | RILUZOLE | SURVIVAL
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record